Skip to content
1632-X-ray Preactivated Nanoparticles for Deep Tumor episode artwork

Sep 30, 2026 21 min

1632-X-ray Preactivated Nanoparticles for Deep Tumor

from Paper Talk

The research paper introduces ETPNs, a novel nanoparticle system designed to treat deep-seated pancreatic tumors using X-ray preactivated photodynamic therapy. These nanoparticles utilize persistent luminescence, allowing them to emit therapeutic light internally after external X-rays are removed, which avoids the risks of continuous radiation. A key feature of the technology is its reversible "on-off" mechanism, which activates the treatment specifically in the acidic microenvironment of a tumor while remaining inactive in healthy tissue. The system further integrates elimusertib, a drug that blocks DNA repair, to synergistically amplify the cellular damage caused by light-induced reactive oxygen species. This combined approach triggers the cGAS-STING immune pathway, effectively transforming "cold" pancreatic tumors into "hot" targets for the body’s own immune system. Ultimately, the study demonstrates that ETPNs can significantly suppress tumor growth and enhance surgical precision through pH-dependent visualization in living models. References: Topatana W, Sun Y, Xie T, et al. X-ray preactivated reversible persistent luminescence enables photodynamic immunotherapy of deep tumors[J]. Nature Communications, 2026, 17(1): 4297. 前往小宇宙评论区与主播互动

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

1632-X-ray Preactivated Nanoparticles for Deep Tumor

0:00 21:29

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Paper Talk?

This episode is 21 minutes long.

When was this Paper Talk episode published?

This episode was published on September 30, 2026.

Can I download this Paper Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.